Genetically Determined Variability in Acetylation and Oxidation

@article{Clark2012GeneticallyDV,
  title={Genetically Determined Variability in Acetylation and Oxidation},
  author={D. D. Clark},
  journal={Drugs},
  year={2012},
  volume={29},
  pages={342-375}
}
  • D. D. Clark
  • Published 2012
  • Biology
  • Drugs
  • SummaryThe clinical significance of two separate genetic polymorphisms which alter drug metabolism, acetylation and oxidation is discussed, and methods of phenotyping for both acetylator and polymorphic oxidation status are reviewed. Particular reference is made to the dapsone method, which provides a simple means of distinguishing fast and slow — and possibly intermediate — acetylators, and to the sparteine method which allows a clear separation of oxidation phenotypes.Although acetylation… CONTINUE READING
    23 Citations

    Figures and Tables from this paper.

    Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.
    • D. Hein, L. Millner
    • Chemistry, Medicine
    • Expert opinion on drug metabolism & toxicology
    • 2020
    Acetylation Phenotype in Colorectal Carcinoma 1
    Complications associated with antibiotic administration: neurological adverse events and interference with antiepileptic drugs.
    • 14
    Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense
    • 5
    • PDF
    2 Chemotherapeutic Strategies and Targets Against Resistant TB

    References

    SHOWING 1-10 OF 241 REFERENCES
    Disease and Acetylation Polymorphism
    • 140
    Clinical consequences of polymorphic acetylation of basic drugs
    • 147
    Kinetic discrimination of three sulfamethazine acetylation phenotypes
    • 41
    Defective Oxidation of Drugs: Pharmacokinetic and Therapeutic Implications
    • 203
    Oxidation phenotype and the metabolism and action of beta-blockers
    • M. Lennard
    • Biology, Medicine
    • Klinische Wochenschrift
    • 2005
    • 11
    Toxicological implications of polymorphic drug metabolism.
    • 20